Cannabis Science, Inc. (OTC:CBIS) works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Their initial focus is on skin cancers, HIV/AIDS, and neurological conditions.